However, with the increasing number of neuritic plaques and NFTs in the brains of AD patients, deposited Aβ and p-tau can activate microglia receptors, generate neuroimmune inflammatory responses, and accelerate the degeneration and death of neurons, ultimately leading to cognitive impairment and dementia (Maccioni et al., 2018). Here, MAPT is linked to Alzheimer disease.